The Psychedelic Invest Podcast

Learn about the leaders that are bringing psychedelic medicines to the mainstream. Hosted by Bruce Eckfeldt, The Psychedelic Invest Podcast, explores the personalities, organizations, and opportunities that come along with the adoption of psychedelics.

Listen on:

  • Apple Podcasts
  • Google Podcasts
  • Podbean App
  • Spotify
  • Amazon Music
  • TuneIn + Alexa
  • iHeartRadio
  • PlayerFM
  • Listen Notes
  • Samsung
  • Podchaser

Episodes

Wednesday Oct 26, 2022

Logan Lenz is the CEO of Nucleus, a venture studio creating brands in the psychedelics industry. Nucleus is currently raising funds through crowdfunding on Wefunder, and allowing anyone to invest in their portfolio of twelve brands with as little as $200. 
As a much-needed disclaimer, Nucleus owns and operates Psychedelic Invest.

Tuesday Oct 18, 2022


On this episode of the Psychedelic Invest Podcast, we welcome Tim Schlidt of Palo Santo.
Palo Santo is a leading therapeutics investment fund dedicated to increasing the global supply of clinically effective and accessible healthcare solutions.
Tim is a Co-Founder and Partner of the fund, sits on the Board of many psychedelics companies, and recently closed a $50 million fund.
Tune in to learn more about Palo Santo's investment thesis, portfolio, and goals for the future of psychedelic-assisted therapies and beyond.

Wednesday Oct 12, 2022


On this episode of the Psychedelic Invest Podcast, we welcome Anand Shahi of BAR Capital.
BAR Capital is a family office focused on continuously raising the standards of excellence for the stewardship of wealth.
Tune in to learn more about how the cannabis industry relates to psychedelics and how trends and patterns might allow us to predict future outcomes. As an investor himself, Anand shines a light on how these comparisons can lead to investment opportunities now and down the road.

Tuesday Oct 04, 2022

On this episode of the Psychedelic Invest Podcast, Bruce Eckfeldt is joined by two of the co-founders of aNUma, a digital group therapeutics startup. aNUma is creating unique VR experiences for palliative care and beyond. 
Tune in to learn more about the men behind this novel idea, what the company is focusing on now, and how their work is positioned relative to the psychedelics industry as a whole.

Tuesday Sep 27, 2022


On this episode of the Psychedelic Invest Podcast, we welcome Jordan Tishler.
Jordan is a lot of things. All of those things revolve around him being a very hard-working and intelligent doctor and entrepreneur.
For starters, he is the CEO of InhaleMD. He's also a Professor at Harvard and the President of the Association of Cannabinoid Specialists.
We're quite fortunate he was able to sit down with host, Bruce Eckfeldt to record this amazing conversation.
We hope you enjoy.

Wednesday Sep 21, 2022

Robbie Bent joins host Bruce Eckfeldt for a conversation about the future of well-being.
More specifically, Robbie is building a platform that includes physical spaces, a mobile app, a concert tour, and a global community.
His company is called Othership and his commitment to helping as many people as possible is clear and obvious.
We hope you enjoy this conversation.

Tuesday Sep 13, 2022

Itzhak Beery joins the Psychedelic Invest Podcast for episode #17. 
Itzhak considers himself a "modern-day shaman." In this episode, we learn what it means to bring old traditions into modern times. 

Wednesday Sep 07, 2022

On this episode of the Psychedelic Invest Podcast, we welcome Doug Finkelstein.
Doug is the Chief Empathy Officer of Empathic Health, a community membership program connecting individuals with events and each other.
During the conversation, Doug highlights his history with plant medicines and how and why Empathic Health was formed. 

Tuesday Aug 30, 2022


Season two episode two brings us a delightful conversation between host Bruce Eckfeldt and Amanda Reiman.
Amanda Reiman, among many other things, is the Co-Founder of Secret Garden, the VP of Public Policy Research at New Frontier Data, and Founder of Personal Plants.
Amanda calls herself a social ethnobotanist. She has been studying the relationship between people and plant medicines for over 20 years. She was one of the first people to explore the use of cannabis as a substitute for alcohol and other drugs. She founded Personal Plants in 2020 to create space for everyone to grow and process their own medicinal plants.
We hope you enjoy the conversation.

Tuesday Aug 23, 2022


To kick things off for season two, host Bruce Eckfeldt is joined by the Co-Founder and CEO of Beckley Retreats, Neil Markey.
As a Captain in the US Army Special Operations 2nd Ranger Battalion, Neil was deployed once to Iraq, and twice to Afghanistan. After, as an MBA/MIA master's student at Columbia University, he suffered from depression and PTSD. This led him to alternative well-being practices and marked the start of a profound healing journey with mindfulness and psychedelics. Prior to Beckley Retreats, Neil worked as the Chief Growth Officer for a $450M private equity portfolio company where he was responsible for all strategy and growth planning. Before that he worked as a consultant at McKinsey & Co, where he co-led the internal mindfulness program.

Image

The Psychedelic Invest Podcast

Learn about the leaders that are bringing psychedelic medicines to the mainstream. Hosted by Bruce Eckfeldt, The Psychedelic Invest Podcast, explores the personalities, organizations, and opportunities that come along with the adoption of psychedelics.

Copyright 2022. Your Finance Buddy, LLC. All rights reserved.

Podcast Powered By Podbean

Version: 20221013